Carleton, PhD, Fiona, United States

• Journal of Opioid Management Vol. 16 No. 3 (2020): May/June - Articles
  An open-label, randomized, single-dose, two-period, two-treatment crossover bioavailability study comparing 5 mg/0.5 mL of intramuscular naloxone hydrochloride to 2 mg/0.4 mL intramuscular naloxone hydrochloride autoinjector in healthy subjects
  Abstract